DeutschNewstral
Article
bizjournals.com on 2022-03-24 19:51
Pfizer's Canadian partner sues Arbutus Biopharma in Covid-19 vaccine patent dispute
Related news
- Arbutus Biopharma wins patent ruling linked to Moderna's Covid-19 vaccine candidatebizjournals.com
Update on Arbutus mRNA Vaccine Patent Litigationsjdsupra.com- LTechnologies for Delivery of Proteins, Antibodies and Nucleic Acids Market 2021-2026 Size and Share, Recent Enhancements and Regional Analysis | Key Companies: Aphios, Arbutus Biopharma, Camurus, C…liverpoolstudentmedia.com
Apple settles patent disputeThe Globe and Mail- Video: Pfizer's profit plummetsThe Globe and Mail
Sweden's Ericsson sues Apple in patent disputeThe Salt Lake Tribune
Court Says Pfizer's Biosimilar of J&J's Remicade Doesn't Infringe Patentwsj.com- VBCGEU sues Vancity over pension disputevoiceonline.com
- Top 10 patent and regulatory things you need to know when bringing a biopharma product to Canadajdsupra.com
- GModerna Sues Pfizer/BioNTech Over COVID Vaccine Patent InfringementGuardian Liberty Voice
- BlackBerry signs license deal with BLU, ends patent disputeThe Globe and Mail
- Nokia shares fall on patent dispute with AppleThe Globe and Mail
- Year-end Round-up: Notable Canadian Patent Cases of 2018jdsupra.com
Canada approves Pfizer's COVID-19 pillisraelnationalnews.com- Arbutus Biopharma Corp. v. ModernaTx, Inc. (Fed. Cir. 2023)jdsupra.com
- Enanta Pharmaceuticals sues Pfizer for patent infringement involving Paxlovidbizjournals.com
- GSK Sues Pfizer for Patent Infringement over RSV Vaccinejdsupra.com
- FSaudi Arabia sells Canadian assets as dispute escalatesft.com
China suspends Canadian meat imports amid Huawei disputeThe Wichita Eagle